IBDEI0NB ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10375,2)
 ;;=^5063035
 ;;^UTILITY(U,$J,358.3,10376,0)
 ;;=Z48.810^^74^677^1
 ;;^UTILITY(U,$J,358.3,10376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10376,1,3,0)
 ;;=3^Aftercare Following EYE Surgery
 ;;^UTILITY(U,$J,358.3,10376,1,4,0)
 ;;=4^Z48.810
 ;;^UTILITY(U,$J,358.3,10376,2)
 ;;=^5063047
 ;;^UTILITY(U,$J,358.3,10377,0)
 ;;=H35.3131^^74^677^40
 ;;^UTILITY(U,$J,358.3,10377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10377,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degn,Early Dry Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10377,1,4,0)
 ;;=4^H35.3131
 ;;^UTILITY(U,$J,358.3,10377,2)
 ;;=^5138511
 ;;^UTILITY(U,$J,358.3,10378,0)
 ;;=H35.3132^^74^677^41
 ;;^UTILITY(U,$J,358.3,10378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10378,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degn,Intermed Dry Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10378,1,4,0)
 ;;=4^H35.3132
 ;;^UTILITY(U,$J,358.3,10378,2)
 ;;=^5138512
 ;;^UTILITY(U,$J,358.3,10379,0)
 ;;=H02.889^^74^677^35
 ;;^UTILITY(U,$J,358.3,10379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10379,1,3,0)
 ;;=3^Meibomian Gland Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,10379,1,4,0)
 ;;=4^H02.889
 ;;^UTILITY(U,$J,358.3,10379,2)
 ;;=^5157349
 ;;^UTILITY(U,$J,358.3,10380,0)
 ;;=Z96.1^^74^677^46
 ;;^UTILITY(U,$J,358.3,10380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10380,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,10380,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,10380,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,10381,0)
 ;;=H43.813^^74^677^53
 ;;^UTILITY(U,$J,358.3,10381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10381,1,3,0)
 ;;=3^Vitreous Degeneration,Bilateral
 ;;^UTILITY(U,$J,358.3,10381,1,4,0)
 ;;=4^H43.813
 ;;^UTILITY(U,$J,358.3,10381,2)
 ;;=^5005955
 ;;^UTILITY(U,$J,358.3,10382,0)
 ;;=H26.491^^74^677^44
 ;;^UTILITY(U,$J,358.3,10382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10382,1,3,0)
 ;;=3^PCO/Secondary Cataract,Right Eye
 ;;^UTILITY(U,$J,358.3,10382,1,4,0)
 ;;=4^H26.491
 ;;^UTILITY(U,$J,358.3,10382,2)
 ;;=^5005358
 ;;^UTILITY(U,$J,358.3,10383,0)
 ;;=H26.492^^74^677^43
 ;;^UTILITY(U,$J,358.3,10383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10383,1,3,0)
 ;;=3^PCO/Secondary Cataract,Left Eye
 ;;^UTILITY(U,$J,358.3,10383,1,4,0)
 ;;=4^H26.492
 ;;^UTILITY(U,$J,358.3,10383,2)
 ;;=^5005359
 ;;^UTILITY(U,$J,358.3,10384,0)
 ;;=D31.31^^74^677^5
 ;;^UTILITY(U,$J,358.3,10384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10384,1,3,0)
 ;;=3^Benign Neop/Nevus Choroid,Right Eye
 ;;^UTILITY(U,$J,358.3,10384,1,4,0)
 ;;=4^D31.31
 ;;^UTILITY(U,$J,358.3,10384,2)
 ;;=^5002121
 ;;^UTILITY(U,$J,358.3,10385,0)
 ;;=D31.32^^74^677^4
 ;;^UTILITY(U,$J,358.3,10385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10385,1,3,0)
 ;;=3^Benign Neop/Nevus Choroid,Left Eye
 ;;^UTILITY(U,$J,358.3,10385,1,4,0)
 ;;=4^D31.32
 ;;^UTILITY(U,$J,358.3,10385,2)
 ;;=^5002122
 ;;^UTILITY(U,$J,358.3,10386,0)
 ;;=H40.1131^^74^677^47
 ;;^UTILITY(U,$J,358.3,10386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10386,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10386,1,4,0)
 ;;=4^H40.1131
 ;;^UTILITY(U,$J,358.3,10386,2)
 ;;=^5138547
 ;;^UTILITY(U,$J,358.3,10387,0)
 ;;=H40.1132^^74^677^48
 ;;^UTILITY(U,$J,358.3,10387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10387,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Moderate Stage,Bilateral
